Skip to main content
In stock | Cellular Therapy

Tabelecleucel

Oncology Type Hematologic
Drug Class / Mechanism Allogeneic EBV-Specific T-Cell Immunotherapy
No Image
Description

Tabelecleucel is classified as an Allogeneic EBV-Specific T-Cell Immunotherapy, sourced for use within our Cellular Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Cellular Therapy
Oncology Type Hematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3